These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia. Meijssen S; van Dijk H; Verseyden C; Erkelens DW; Cabezas MC Arterioscler Thromb Vasc Biol; 2002 May; 22(5):811-6. PubMed ID: 12006395 [TBL] [Abstract][Full Text] [Related]
3. Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia. Ylitalo K; Pajukanta P; Meri S; Cantor RM; Mero-Matikainen N; Vakkilainen J; Nuotio I; Taskinen MR Arterioscler Thromb Vasc Biol; 2001 May; 21(5):838-43. PubMed ID: 11348883 [TBL] [Abstract][Full Text] [Related]
4. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Yang Y; Lu HL; Zhang J; Yu HY; Wang HW; Zhang MX; Cianflone K Int J Obes (Lond); 2006 Mar; 30(3):439-46. PubMed ID: 16302015 [TBL] [Abstract][Full Text] [Related]
5. Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia. Halkes CJ; van Dijk H; Verseyden C; de Jaegere PP; Plokker HW; Meijssen S; Erkelens DW; Cabezas MC Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1875-80. PubMed ID: 12933534 [TBL] [Abstract][Full Text] [Related]
6. Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia. Verseyden C; Meijssen S; van Dijk H; Jansen H; Castro Cabezas M J Lipid Res; 2003 Nov; 44(11):2100-8. PubMed ID: 12923226 [TBL] [Abstract][Full Text] [Related]
7. Hyperlipidemia and serum complement. Cucuianu M Atherosclerosis; 1998 Apr; 137(2):441-2. PubMed ID: 9622289 [No Abstract] [Full Text] [Related]
9. Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome. Ozata M; Oktenli C; Gulec M; Ozgurtas T; Bulucu F; Caglar K; Bingol N; Vural A; Ozdemir IC J Clin Endocrinol Metab; 2002 Feb; 87(2):853-8. PubMed ID: 11836332 [TBL] [Abstract][Full Text] [Related]
10. Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus. van der Kallen CJ; Voors-Pette C; Bouwman FG; Keizer HA; Lu JY; van de Hulst RR; Bianchi R; Janssen MJ; Keulen ET; Boeckx WD; Rotter JI; de Bruin TW Atherosclerosis; 2002 Oct; 164(2):337-46. PubMed ID: 12204806 [TBL] [Abstract][Full Text] [Related]
11. A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia. Kildsgaard J; Zsigmond E; Chan L; Wetsel RA Mol Immunol; 1999; 36(13-14):869-76. PubMed ID: 10698341 [TBL] [Abstract][Full Text] [Related]
12. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy. Arca M; Natoli S; Micheletta F; Riggi S; Di Angelantonio E; Montali A; Antonini TM; Antonini R; Diczfalusy U; Iuliano L Free Radic Biol Med; 2007 Mar; 42(5):698-705. PubMed ID: 17291993 [TBL] [Abstract][Full Text] [Related]
13. Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia. Ylitalo K; Syvänne M; Salonen R; Nuotio I; Taskinen MR; Salonen JT Atherosclerosis; 2002 May; 162(1):171-8. PubMed ID: 11947911 [TBL] [Abstract][Full Text] [Related]
14. Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Koistinen HA; Vidal H; Karonen SL; Dusserre E; Vallier P; Koivisto VA; Ebeling P Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1034-9. PubMed ID: 11397716 [TBL] [Abstract][Full Text] [Related]